CSL Limited (OTCMKTS:CSLLY) Short Interest Down 94.6% in July

CSL Limited (OTCMKTS:CSLLY) saw a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 1,200 shares, a decline of 94.6% from the June 30th total of 22,400 shares. Based on an average trading volume of 41,200 shares, the short-interest ratio is presently 0.0 days.

CSL Trading Down 0.8 %

OTCMKTS:CSLLY traded down $0.85 during midday trading on Friday, reaching $101.50. 16,088 shares of the company traded hands, compared to its average volume of 33,658. CSL has a twelve month low of $71.51 and a twelve month high of $106.82. The company has a fifty day moving average price of $97.67 and a 200 day moving average price of $94.79.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.